Pfizer (NYSE: PFE) Stock Drops Despite Positive Regulatory News on Hemophilia B Gene Therapy
Pfizer (NYSE: PFE) stock fell more than 2% on Thursday, even though Canadian regulators approved its Gene Therapy for Hemophilia […]
Pfizer (NYSE: PFE) stock fell more than 2% on Thursday, even though Canadian regulators approved its Gene Therapy for Hemophilia […]
Shares of Pfizer Inc. (NYSE: PFE) and German partner BioNTech (NASDAQ: BNTX) fell in pre-market trading after the leading U.S.